Biotech · Private company
Lutris Pharma Ltd.
Track this companyFree. Adds Lutris Pharma Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- LUT014 GelPhase 2 · Radiation DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- LUT014 Gel (Dose 1)Phase 2 · EGFRI Induced Acneiform LesionsClinicalTrials.gov · fetched Nov 12, 2026
- LUT014 Gel (Dose 2)Phase 2 · EGFRI Induced Acneiform LesionsClinicalTrials.gov · fetched Nov 12, 2026
- LUT014Phase 1 · EGFR Inhibitor Induced Acneiform LesionsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRCPHASE2 · UNKNOWN · started Apr 12, 2021ClinicalTrials.gov NCT04759664 · fetched Nov 12, 2026
- LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer PatientsPHASE1_PHASE2 · COMPLETED · started Jan 30, 2021ClinicalTrials.gov NCT04261387 · fetched Nov 12, 2026
- A Study of LUT014 in Patients With Metastatic Colorectal Cancer With EGFR Inhibitor Induced Acneiform LesionsPHASE1 · COMPLETED · started Aug 21, 2019ClinicalTrials.gov NCT03876106 · fetched Nov 12, 2026